Loading stock data…
FEED
$1.19+0.03 (+2.59%)
Market ClosedLast close May 1
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
ENvue Medical, Inc. in the Healthcare sector is trading at $1.19. The stock is currently near its 52-week low of $0.99, remaining 71.8% below its 200-day moving average. Technical signals show oversold RSI of 23 and bearish MACD signal, explaining why FEED maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 23) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.19
Potential Upside
5%
Whystock Fair Value$1.25
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.92M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.10
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-15.93%
Volume
Today's trading volume
131,873
Recent News
BC-Most Active Stocks
Nu Holdings Ltd. 45,229,536 14.51
ENvue Medical Insider Ups Holding During Year
Insiders were net buyers of ENvue Medical, Inc.'s ( NASDAQ:FEED ) stock during the past year. That is, insiders bought...
ENvue Medical announces launch of new development, integration program
ENvue Medical (FEED) announced the launch of a new development and integration program leveraging vibration-based technology from its NanoVibronix division to address pain and discomfort associated with indwelling nasogastric tubes. Doron Besser, MD, CEO of ENvue Medical, commented, “We believe that this program represents a disciplined platform expansion initiative focused on improving the overall enteral care experience by addressing patient comfort during prolonged NG tube use. While this ini